These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 1997182

  • 1. In vivo and in vitro mechanisms of drug resistance in a rat mammary carcinoma model.
    Schecter RL, Woo A, Duong M, Batist G.
    Cancer Res; 1991 Mar 01; 51(5):1434-42. PubMed ID: 1997182
    [Abstract] [Full Text] [Related]

  • 2. Radiation resistance in a melphalan-resistant subline of a rat mammary carcinoma.
    Lehnert S, Vestergaard J, Batist G, Aloui-Jamali MA.
    Radiat Res; 1994 Aug 01; 139(2):232-9. PubMed ID: 8052700
    [Abstract] [Full Text] [Related]

  • 3. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity.
    Schecter RL, Alaoui-Jamali MA, Woo A, Fahl WE, Batist G.
    Cancer Res; 1993 Oct 15; 53(20):4900-6. PubMed ID: 8402679
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY, Teicher BA, Shea TC, Holden SA, Rosbe KW, al-Achi A, Henner WD.
    Cancer Res; 1989 Nov 15; 49(22):6185-92. PubMed ID: 2804968
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells.
    Mimnaugh EG, Dusre L, Atwell J, Myers CE.
    Cancer Res; 1989 Jan 01; 49(1):8-15. PubMed ID: 2535695
    [Abstract] [Full Text] [Related]

  • 9. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184.
    Moy BC, Petzold GL, Badiner GJ, Kelly RC, Aristoff PA, Adams EG, Li LH, Bhuyan BK.
    Cancer Res; 1990 Apr 15; 50(8):2485-92. PubMed ID: 2317831
    [Abstract] [Full Text] [Related]

  • 10. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
    Lee FY, Sciandra J, Siemann DW.
    Biochem Pharmacol; 1989 Nov 01; 38(21):3697-705. PubMed ID: 2574574
    [Abstract] [Full Text] [Related]

  • 11. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ.
    Cancer Res; 1988 Jul 01; 48(13):3595-602. PubMed ID: 2897875
    [Abstract] [Full Text] [Related]

  • 12. Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line.
    Batist G, Torres-Garcia S, Demuys JM, Greene D, Lehnert S, Rochon M, Panasci L.
    Mol Pharmacol; 1989 Aug 01; 36(2):224-30. PubMed ID: 2770701
    [Abstract] [Full Text] [Related]

  • 13. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
    Evans CG, Bodell WJ, Tokuda K, Doane-Setzer P, Smith MT.
    Cancer Res; 1987 May 15; 47(10):2525-30. PubMed ID: 2882834
    [Abstract] [Full Text] [Related]

  • 14. Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblasts.
    Greenbaum M, Létourneau S, Assar H, Schecter RL, Batist G, Cournoyer D.
    Cancer Res; 1994 Aug 15; 54(16):4442-7. PubMed ID: 8044793
    [Abstract] [Full Text] [Related]

  • 15. Radiation response of drug-resistant variants of a human breast cancer cell line: the effect of glutathione depletion.
    Lehnert S, Greene D, Batist G.
    Radiat Res; 1990 Nov 15; 124(2):208-15. PubMed ID: 2247601
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N, Lam YM, Pym J, Campling BG.
    Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M, Hao XY, Larsson R, Nygren P, Tsuruo T, Mannervik B, Bergh J.
    Anticancer Res; 1993 May 01; 13(5A):1425-30. PubMed ID: 7902062
    [Abstract] [Full Text] [Related]

  • 19. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
    Moscow JA, Townsend AJ, Cowan KH.
    Mol Pharmacol; 1989 Jul 01; 36(1):22-8. PubMed ID: 2747627
    [Abstract] [Full Text] [Related]

  • 20. Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype.
    Chen G, Teicher BA, Frei E.
    Cancer Biochem Biophys; 1998 Jun 01; 16(1-2):139-55. PubMed ID: 9923973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.